Australia's Race Oncology rises on drug breakthrough; set for record best week

Racura Oncology

19/09/2025 05:49

** Shares of Australia's Race Oncology  RAC.AX rise as much as 23.7% to A$3.180, its highest level since mid-January 2022

** Stock on track to mark its best week ever, if gains hold

** Biopharmaceutical co on Tuesday made discovery involving composition matter of chemotherapy drug Bisantrene

** Based on discovery, co had filed 3 patent applications

** Stock has risen 128.9% this year, including session gains

 (Reporting by Roshan Thomas in Bengaluru)

 ((Roshan.Thomas@thomsonreuters.com;))